Current
22.0×
5-Year Average
25.7×
All-Time High
56.2×
All-Time Low
8.9×
P/E Ratio daily chart for CME Group (CME)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/E Ratio for CME Group (CME) from 2002 to 2025
| 2025 | $98.21B | $4.04B | 24.3× | +0.6× | |
| 2024 | $83.46B | $3.53B | 23.7× | +0.2× | |
| 2023 | $75.65B | $3.23B | 23.4× | +1.0× | |
| 2022 | $60.35B | $2.69B | 22.4× | -8.6× | |
| 2021 | $81.92B | $2.64B | 31.1× | +0.1× | |
| 2020 | $65.18B | $2.11B | 31.0× | -2.9× | |
| 2019 | $71.75B | $2.12B | 33.9× | +0.3× | |
| 2018 | $66.02B | $1.96B | 33.6× | +21.5× | |
| 2017 | $49.53B | $4.06B | 12.2× | -13.2× | |
| 2016 | $39.00B | $1.53B | 25.4× | +0.9× | |
| 2015 | $30.52B | $1.25B | 24.5× | -1.9× | |
| 2014 | $29.72B | $1.13B | 26.4× | -0.4× | |
| 2013 | $26.18B | $976.80M | 26.8× | +8.0× | |
| 2012 | $16.81B | $896.30M | 18.8× | +9.9× | |
| 2011 | $16.11B | $1.81B | 8.9× | -13.7× | |
| 2010 | $21.50B | $951.40M | 22.6× | -4.3× | |
| 2009 | $22.25B | $825.80M | 26.9× | +9.5× | |
| 2008 | $12.46B | $715.49M | 17.4× | -32.3× | |
| 2007 | $32.76B | $658.53M | 49.7× | +6.2× | |
| 2006 | $17.75B | $407.35M | 43.6× | +2.3× | |
| 2005 | $12.67B | $306.86M | 41.3× | +5.9× | |
| 2004 | $7.77B | $219.56M | 35.4× | +15.9× | |
| 2003 | $2.38B | $122.13M | 19.5× | +3.4× | |
| 2002 | $1.42B | $88.45M | 16.1× | — |
- 202524.3×
- 202423.7×
- 202323.4×
- 202222.4×
- 202131.1×
- 202031.0×
- 201933.9×
- 201833.6×
- 201712.2×
- 201625.4×
- 201524.5×
- 201426.4×
- 201326.8×
- 201218.8×
- 20118.9×
- 201022.6×
- 200926.9×
- 200817.4×
- 200749.7×
- 200643.6×
- 200541.3×
- 200435.4×
- 200319.5×
- 200216.1×
About P/E Ratio at CME Group (CME)
CME Group (CME) P/E ratio is 22.0× as of June 5, 2026. The 5-year average is 25.7×. The sector median currently stands at 12.8×. The current ratio is at the 3th percentile of its own 10-year history.
CME Group (CME) historical P/E ratio has ranged from a low of 8.9× (2011) to a high of 56.2× (2007) in the available daily series.
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
CME Group P/E Ratio by Year
CME Group P/E Ratio 2025: 24.3×
CME Group (CME) P/E ratio in 2025 was 24.3×, expanded from 23.7× the prior year.
CME Group P/E Ratio 2024: 23.7×
CME Group (CME) P/E ratio in 2024 was 23.7×, expanded from 23.4× the prior year.
CME Group P/E Ratio 2023: 23.4×
CME Group (CME) P/E ratio in 2023 was 23.4×, expanded from 22.4× the prior year.
CME Group P/E Ratio 2022: 22.4×
CME Group (CME) P/E ratio in 2022 was 22.4×, contracted from 31.1× the prior year.
CME Group P/E Ratio 2021: 31.1×
CME Group (CME) P/E ratio in 2021 was 31.1×.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Financial Services peers of CME Group (CME), ranked by P/E ratio.
| 9.7× | |
| 9.7× | |
| 9.6× | |
| 9.6× | |
| 9.5× | |
| 9.3× | |
| 9.3× | |
| 9.3× | |
| 8.9× | |
| 8.8× | |
| 8.8× | |
| 8.7× | |
| 8.3× | |
| 8.2× | |
| 8.0× | |
| 7.6× | |
| 7.5× | |
| 7.1× | |
| 7.0× | |
| 6.7× | |
| 6.5× | |
| 6.5× | |
| 5.8× | |
| 4.5× | |
| 4.4× |
- 9.3×
- 8.2×
- 4.4×
Frequently asked questions
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric